THURSDAY, July 6, 2023 (HealthDay News) — Stimulant medications like Ritalin are commonly prescribed to help treat the symptoms of attention deficit hyperactivity disorder, but there have been concerns the drugs may lay the groundwork for later substance abuse. New research may now set those worries at ease. Children whoContinue Reading

WEDNESDAY, July 5, 2023 (HealthDay News) — Medical marijuana is touted as a pain reliever, but in U.S. states where it’s legal, prescriptions for opioid or non-opioid painkillers haven’t decreased, a new study finds. According to researchers, this means that people aren’t switching to cannabis for pain relief in hugeContinue Reading

TUESDAY, July 4, 2023 (HealthDay News) — Bacteria found in hospital patients in Ukraine is showing extreme antibiotic resistance, making it harder to treat the wounded and ill in this war-torn country, new research warns. “I am quite thick-skinned and have witnessed numerous situations involving patients and bacteria,” said studyContinue Reading

THURSDAY, June 29, 2023 (HealthDay News) — Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday. On Thursday, Dr. Rochelle Walensky, the outgoing CDC director, gave her signature to a recommendation made lastContinue Reading

TUESDAY, June 27, 2023 (HealthDay News) — “Superbug” infections are increasing in U.S. hospitals, and a coalition of medical groups has now issued a set of updated recommendations to protect patients. These guidelines are meant to prevent the spread of methicillin-resistant Staphylococcus aureus, also known as MRSA, the authors ofContinue Reading

TUESDAY, June 27, 2023 (HealthDay News) — An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows. Retatrutide helped people with obesity drop about one-quarter of their starting weight, on average, during 48 weeksContinue Reading

MONDAY, June 26, 2023 (HealthDay News) — One in 10 people with high blood pressure suffer from a treatment-resistant type of hypertension, yet these patients aren’t always getting the right medication, a new study finds. “Apparent resistant hypertension [aRH] is more common than many would anticipate,” said researcher Dr. JosephContinue Reading

WEDNESDAY, June 21, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Tuesday approved two drugs that have been used in adults with type 2 diabetes for years for use in children aged 10 and up. The approvals of Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) provideContinue Reading